The 2024 grant cycle is now open.<\/b><\/span><\/p>\n<\/div><\/div><\/div> Since 2002, the Barth Syndrome Foundation, Inc. and its affiliates have been awarding research grants. The Barth Syndrome Foundation of Canada have participated in their Research Grant program since 2006, and have contributed towards 17 individual grants for a total of over $400,000 US (see below for details). Together with BSF and the other affiliates (UK, France and Italy), 115 research grants have been awarded to 68 principle investigators worldwide, for a total of US $6.4 million.<\/p>\n The 2024 grant cycle is now open<\/b>. At this time, the Barth Syndrome Foundation (BSF) and its international affiliates will welcome innovative applications that address the basic, translational, and clinical research challenges of Barth syndrome. BSF seeks to provide seed grant funding to young and established investigators in order to generate the preliminary data required for successful follow-on funding available from major grant-making institutions.<\/p>\n More information about the program and key dates can be found at BSF<\/a><\/u>.<\/a><\/p>\n<\/div><\/div><\/div> Melissa Huang, PhD<\/p>\n Clinical Research Coordinator<\/span><\/p>\n Barth Syndrome Foundation, Inc.<\/span><\/p>\n melissa.huang@barthsyndrome.org<\/u><\/a><\/p>\n bsfinfo@barthsyndrome.org<\/a><\/u> Note that BSF has adjusted their grant year naming convention, so 2019 was not considered a grant year.<\/span><\/p>\n Click here for a complete list of active grants<\/a><\/u> awarded by BSF and affiliates. Following is a list of grants funded or partially funded by BSFCa.<\/span><\/p>\n<\/div><\/div><\/div> Kate Schroder, PhD<\/b>, Elucidating Cardiolipin Immune Dysfunction in Barth Syndrome<\/u><\/a><\/p>\n This research is currently on-going.<\/span><\/p>\n *Funding for this award was provided by Barth Syndrome Foundation and Barth Syndrome Foundation of Canada.<\/i><\/p>\n<\/div> Borko Amulic, PhD<\/span> Investigating the basis of neutropenia in Barth syndrome<\/a><\/u><\/p>\n This research is currently on-going.<\/span><\/p>\n *Funding for this award was provided by Barth Syndrome UK, and Barth Syndrome Foundation of Canada.<\/i><\/p>\n<\/div><\/div><\/div> Jason Moffat, PhD<\/span> Surveying TAZ genetic interactions and mutational landscape in human cells<\/a><\/u>. This research is currently on-going.<\/span><\/p>\n *Funding for this award was provided by Barth Syndrome UK, and Barth Syndrome Foundation of Canada.<\/i><\/p>\n<\/div> Robin E. Duncan, PhD<\/b> Investigation of a new nutraceutical for treatment of Barth Syndrome<\/a><\/u>. This research is currently on-going.<\/span><\/p>\n *Funding for this award was provided by Barth Syndrome UK, and Barth Syndrome Foundation of Canada.<\/i><\/p>\n<\/div> Christopher Y. Park, MD, PhD<\/b> Characterization of hematopoietic stem and progenitor cells in Barth syndrome<\/a><\/u>. This research is currently on-going.<\/span><\/p>\n *Funding for this award was provided by Barth Syndrome France, and Barth Syndrome Foundation of Canada.<\/i><\/p>\n<\/div> Richard Epand, PhD<\/b> The cause and consequences of plasmalogen depletion in Barth syndrome<\/a><\/u>. This research is currently on-going.<\/span><\/p>\n Associated publications to date:<\/p>\n *Funding for this award was provided by the Barth Syndrome Foundation, and the Barth Syndrome Foundation of Canada.<\/i><\/p>\n<\/div> Christina Pacak, PhD Optimization of AAV-mediated gene therapy for Barth syndrome<\/a><\/u>. This research is currently on-going.<\/span><\/p>\n Associated publications to date:<\/p>\n *Funding for this award was provided by Barth Syndrome France, and Barth Syndrome Foundation of Canada.<\/i><\/p>\n<\/div> Robin Duncan<\/b> A new enzyme and pathway in cardiolipin synthesis<\/a>. This research is currently on-going<\/span><\/p>\n *Funding for this award was provided by Barth Syndrome France, and Barth Syndrome Foundation of Canada.<\/i><\/p>\n<\/div> Valerian Kagan, PhD<\/b> Mechanism and role of cardiolipin oxidation and hydrolysis in Barth syndrome<\/a><\/u>. Associated publications to date:<\/span><\/p>\n Associated presentations to date:<\/p>\n *Funding for this award was provided by Barth Syndrome France, and Barth Syndrome Foundation of Canada.<\/i><\/p>\n<\/div> Grant Hatch, PhD<\/b> Tafazzin knockdown alters hepatic lipid metabolism. Associated publications to date:<\/span><\/p>\n2024 Request for Research Proposals<\/h3>\n
Contact Information<\/h3>\n
\n<\/span>Toll Free: 855-662-2784 (855-NO-BARTH)<\/span><\/p>\n<\/div><\/div><\/div>Previous Grants Awarded<\/h2>\n
2023<\/h3>\n
\n<\/b>The University of Queensland, Australia<\/i><\/p>\n2022<\/h3>\n
\n<\/b>University of Bristol, Bristol, UK<\/i><\/p>\n2021<\/h3>\n
\n<\/b>Professor, University of Toronto, Toronto, ON, Canada<\/i><\/p>\n2020<\/h3>\n
\nAssociate Professor, University of Waterloo, Waterloo, ON, Canada<\/i><\/p>\n2018<\/h3>\n
\nAssociate Professor, New York University School of Medicine, New York, NY<\/i><\/p>\n2017<\/h3>\n
\nProfessor, McMaster University, Hamilton, Ontario, Canada<\/i><\/p>\n\n
2016<\/h3>\n
\n<\/b>Assistant Professor, University of Florida, Gainesville, FL<\/p>\n\n
2015<\/h3>\n
\nAssistant Professor, University of Waterloo, Waterloo, Ontario<\/p>\n2014<\/h3>\n
\nProfessor and Vice-Chairman, University of Pittsburgh, Pittsburgh, PA<\/span><\/span><\/p>\n\n
\n
2013<\/h3>\n
\nProfessor, University of Manitoba, Winnipeg, Manitoba<\/p>\n